As mutations in RAS account for 30% of human cancer and the expression of KRasG12D in epidermal keratinocytes induces SCC formation in the skin [44], KRasG12D mouse models are thus widely used to discern the role of KRas in the development of cancer [45,46]. This evidence concerns the gene KRAS and cancer.